Multi-mode lung cancer risk dynamic assessment system and method thereof

The multimodal lung cancer risk dynamic assessment system integrates family history, gene mutation, and environmental exposure data using topology and adaptive attention gating technology, which solves the shortcomings of existing multidimensional risk assessment technologies and achieves accurate and dynamic lung cancer risk assessment and personalized intervention recommendations.

CN121662365APending Publication Date: 2026-03-13GUANGDONG OPTO MEDIC TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-10-30
Publication Date
2026-03-13

AI Technical Summary

Technical Problem

Existing lung cancer risk assessment methods lack comprehensive consideration of multidimensional risk factors, cannot effectively capture the complex interactions between different risk factors, lack adaptability to dynamic changes in risk factors, fail to deeply integrate multimodal data such as family history, gene mutations, and environmental exposure, and the assessment results lack interpretability, making it difficult to provide clinicians with targeted intervention recommendations.

Method used

By constructing a multimodal dynamic assessment system for lung cancer risk, and utilizing topological theory and adaptive attention gating technology, the system integrates genetic, environmental, and family history data to construct family history topology maps, gene mutation topology maps, and environmental exposure topology maps. It performs continuous cohomology analysis, calculates interaction coefficients, generates cross-modal collaborative amplification networks, and provides risk decomposition reports.

Benefits of technology

It achieves deep fusion of multimodal data, accurately quantifies the interaction of risk factors, dynamically adapts to changes in risk, provides interpretable assessment results, improves screening accuracy and prediction accuracy, reduces false positive rate, and provides a scientific basis for personalized intervention programs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121662365A_ABST
    Figure CN121662365A_ABST
Patent Text Reader

Abstract

The invention discloses a multi-modal lung cancer risk dynamic assessment system and method, and belongs to the technical field of medical data analys.The multi-modal lung cancer risk dynamic assessment system comprises a data acquisition module, a topological representation module, a self-adaptive attention gating module, a risk assessment module and a feedback optimization module; the method comprises the following steps: constructing a family history topological graph, a gene mutation topological graph and an environmental exposure topological graph, extracting multi-level topological features, generating a continuous bar code and a Betti number sequence based on continuous homology analysis, calculating an interaction coefficient, and triggering a cross-modal risk collaborative amplification mechanism when a gene mutation and environmental toxin coexistence mode is detected. The system is further provided with a three-level collaborative amplification mechanism, a risk decomposition report containing gene risks, environment risks, family risks and collaborative amplification factors is generated, dynamic parameter optimization is achieved by calculating the topological entropy change rate, deep fusion of multi-modal data is achieved, and the risk factor interaction effect is accurately quantified.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of medical data analysis technology, and in particular to a multimodal dynamic risk assessment system and method for lung cancer, which can be applied to early risk prediction and precision prevention of lung cancer. Background Technology

[0002] Lung cancer is one of the leading causes of cancer-related morbidity and mortality worldwide. Current lung cancer risk assessment methods primarily rely on single-dimensional data, such as genetic testing or imaging examinations, lacking a comprehensive consideration of multi-dimensional risk factors. Existing technologies have the following shortcomings: First, traditional lung cancer risk assessment models typically integrate risk factors using a simple linear weighting method, which fails to effectively capture the complex interactions between different risk factors. For example, the coexistence of smoking and specific gene mutations may generate a risk increase beyond simple additive effects, but existing models struggle to accurately quantify this synergistic effect.

[0003] Secondly, most existing risk assessment systems are static models, lacking the ability to adapt to dynamic changes in risk factors. Patients' environmental exposures, lifestyle habits, and other risk factors all change over time, and static models cannot reflect the impact of these dynamic changes on risk assessment.

[0004] Third, current technologies lack in-depth integration of multimodal data such as family history, gene mutations, and environmental exposures. Although studies have shown that these three types of factors have a significant impact on the risk of lung cancer, constructing a unified mathematical framework to effectively integrate these heterogeneous data remains a challenge.

[0005] Fourth, existing risk assessment results often lack interpretability, making it difficult to provide clinicians with targeted intervention recommendations. The specific factors behind risk scores and their contribution are unclear, limiting the development of personalized intervention plans.

[0006] Therefore, there is an urgent need to develop a system that can dynamically and accurately assess the risk of lung cancer, and achieve deep fusion and analysis of multimodal data to provide strong support for the early prevention and intervention of lung cancer. Summary of the Invention

[0007] The purpose of this invention is to provide a multimodal dynamic assessment system and method for lung cancer risk. By integrating data from three aspects—genetics, environment, and family history—and utilizing topological theory and adaptive attention gating technology, it achieves accurate and dynamic assessment of lung cancer risk.

[0008] This invention proposes a multimodal dynamic assessment system for lung cancer risk, comprising: The data acquisition module is used for: Collect user family genealogy data, which includes lung cancer history and blood relationship among three generations of relatives; Collect germline gene sequencing data, which includes user gene mutation information; Collect environmental exposure data, which includes historical records of users' occupational trajectories and geographic information; The topology characterization module, connected to the data acquisition module, is used for: Receive the family genealogy data and construct a family history topology map; Receive the germline gene sequencing data, identify mutation sites in driver gene functional domains, and construct a gene mutation topology map; Receive the environmental exposure data and construct an environmental exposure topology map; Multi-level topological features were extracted from the family history topology map, gene mutation topology map, and environmental exposure topology map. The adaptive attention gating module, connected to the topology representation module, is used for: Receive the multi-level topological features; Construct a multi-scale risk filter sequence; Based on the multi-scale risk filter sequence, a persistent coherence analysis is performed to generate persistent barcode and Betti number sequences; Based on the continuous barcode and Betty number sequence, a homology sensitivity matrix is ​​constructed; When a coexistence pattern of gene mutation and environmental toxin is detected, the interaction coefficient is calculated based on the homology sensitivity matrix. When the interaction coefficient exceeds a preset threshold, a cross-modal risk amplification mechanism is triggered. The risk assessment module, connected to the adaptive attention gating module, is used for: Receive the interaction coefficient; Construct homotopy group coding to form a cross-modal cooperative amplification network; Based on the aforementioned cross-modal collaborative amplification network, a comprehensive lung cancer risk score is calculated; Generate a risk decomposition report, which includes genetic risk, environmental risk, family risk, and synergistic amplification factor; The feedback optimization module, connected to the risk assessment module and the adaptive attention gating module, is used for: Receive the comprehensive lung cancer risk score and clinical validation data; Calculate the rate of change of topological entropy; When the rate of change of the topological entropy exceeds the preset fluctuation threshold, a parameter adjustment instruction is sent to the adaptive attention gating module; Based on the clinical validation data, the multi-scale risk filter sequence was optimized.

[0009] Preferably, the topology characterization module includes: Family history topology unit, used for: Receive the family pedigree data; Construct a directed graph of family relationships, setting family members as nodes and blood relations as edges; The incidence of illness among immediate family members is given a high weight, while the incidence of illness among collateral family members is given a decreasing weight. Calculate the shortest path between nodes and generate a family history topology graph; Gene mutation topology unit, used for: Receive the germline gene sequencing data; Identify gene mutation sites, construct functional networks, and set mutation sites as nodes and functional associations as edges; The mutation sites were stratified into three levels: high-risk, intermediate-risk, and low-risk. Calculate the topological centrality and clustering coefficient of functional domain mutations to generate a gene mutation topology map; Environmentally exposed topology units are used for: Receive the environmental exposure data; Construct a spatiotemporal exposure network, setting exposure events as nodes and spatiotemporal associations as edges; Calculate cumulative exposure and construct an exposure intensity heatmap; Extract exposure peak points and continuous exposure patterns to generate an environmental exposure topology map; Multi-level feature extraction unit, used for: Microscopic, mesoscopic, and macroscopic topological features are extracted from the family history topology map, gene mutation topology map, and environmental exposure topology map. The microscopic, mesoscopic, and macroscopic topological features are organized into a multi-level topological feature vector set.

[0010] Preferably, the adaptive attention gating module includes: Multi-scale filter building blocks are used for: Define a risk threshold sequence that increases from low risk to high risk; For each risk threshold, construct a subgraph set, retaining only nodes and edges whose risk values ​​are greater than or equal to that threshold; Form nested sequences to generate multi-scale topological descriptions; The continuous coherence calculation unit, connected to the multi-scale filter construction unit, is used for: Receive the multi-scale topology description; Track the appearance and disappearance of topological features to generate a persistent barcode map; Calculate the Betty number sequence to quantify topological changes under different risk thresholds; Identify Betty number mutation points to indicate key risk topological shifts; The interaction coefficient calculation unit, connected to the continuous coherence calculation unit, is used for: Analyze the persistent barcode crossover patterns of gene-environment pairs; The interaction strength coefficient is calculated based on the degree of barcode overlap and persistence. Apply a piecewise smoothing function to ensure the continuity of coefficient changes; When a high-risk topology is detected, the interaction coefficient will be increased to a level above a preset threshold.

[0011] Preferably, the risk assessment module includes: Hotopy group coding unit, used for: Calculate the fundamental group for each topological space to capture the toroidal structure of the space; Construct homotopy mappings to establish topological equivalence relationships between data of different modalities; Calculate homotopy group invariants to identify essential characteristics of topological structures; Constructing a risk representation space based on homotopy group characteristics; The cooperative amplification unit, connected to the homotopy group encoding unit, is used for: Calculate the interaction strength between homotopy groups of data from different modalities; Identify data combinations with highly coupled homotopy groups; When the coupling strength exceeds the threshold, the cooperative amplification mechanism is triggered; The risk score is dynamically adjusted to reflect the synergistic effect of multiple factors. The risk report generation unit, connected to the collaborative amplification unit, is used for: Receive the adjusted risk score; Decompose the risk components and identify the main risk factors; Generate a risk breakdown report; Provide personalized intervention recommendations.

[0012] Preferably, the feedback optimization module includes: Topological entropy monitoring unit, used for: Continuously monitor changes in topological features; Calculate the rate of change of topological entropy; An alarm signal is generated when the rate of change of topological entropy exceeds a preset fluctuation threshold. The parameter adjustment unit, connected to the topology entropy monitoring unit, is used for: Receive the alarm signal; Generate parameter adjustment instructions; The parameter adjustment command is sent to the adaptive attention gating module; Model validation unit, used for: Receive clinical validation data; Assess the accuracy of model predictions; Identify prediction error patterns; Optimize model parameters based on prediction error patterns.

[0013] Preferably, the data acquisition module further includes: Saliva sample collection unit, used for: Collect saliva samples from users; Extracting user genomic DNA; Quality control was performed on the genomic DNA; The DNA sequencing unit, connected to the saliva sample collection unit, is used for: Receive the genomic DNA; Constructing DNA sequencing libraries; Perform high-throughput sequencing; Generate raw sequencing data; Environmental data collection unit, used for: Collect users' historical occupational data; Collect historical data on users' residential locations; Obtain historical pollutant concentration data from environmental monitoring databases; Link user location and environmental monitoring data to generate a personalized environmental exposure history.

[0014] Preferably, the microscopic topological features extracted by the multi-level feature extraction unit include: Degree centrality, which represents the number of node connections and reflects the scope of influence of risk factors; Intermediation centrality, which represents the importance of a node's position in a path and reflects its risk transmission capability; Proximity centrality, which represents the average distance from a node to other nodes, reflects the speed of risk diffusion; The mesoscopic topological features include: Community segmentation, which is used to identify highly correlated risk factor groups; Modularity, which is used to assess the clarity of risk factor grouping; Inter-community connectivity, which is used to assess the intensity of interaction between different risk groups; The macroscopic topological features include: Network diameter, which represents the length of the longest and shortest paths, reflects the scope of risk impact; Average path length, which represents the average distance between nodes and reflects the efficiency of risk transmission; Clustering coefficient, which represents the overall degree of clustering of the network and reflects the degree of risk coordination.

[0015] Preferably, the Betty number sequence generated by the continuous homology calculation unit includes: The zero-order Betti number, which represents the number of connected components; The first-order Betti number, which represents the number of ring structures; The second-order Betti number, which represents the number of void structures; Among them, when the first-order Betty value suddenly increases, it indicates the formation of a ring-shaped risk structure, triggering a collaborative amplification mechanism; and the formation of a high-risk interaction mode based on the dynamic change rate of the Betty number.

[0016] Preferably, the collaborative amplification unit is provided with a three-stage collaborative amplification mechanism, including: Primary synergy, which is triggered when a single high-risk factor is present, has an amplification factor of 1.2 times the original risk; Intermediate synergy, which is triggered when two types of risk factors coexist, has an amplification factor of 1.8 times that of the original risk; Advanced synergy, which is triggered when three types of risk factors resonate, has an amplification factor of 2.5 times that of the original risk; The risk factors include high-risk gene mutations, a high-risk family history of genetic disease, and a history of high environmental exposure.

[0017] A multimodal dynamic assessment method for lung cancer risk includes the following steps: Collect multimodal data, including user family pedigree data, germline gene sequencing data, and environmental exposure data; Constructing topological representations specifically includes: Based on the aforementioned family pedigree data, a family history topology map is constructed; Based on the germline gene sequencing data, mutation sites in driver gene functional domains were identified, and a gene mutation topology map was constructed. Based on the environmental exposure data, an environmental exposure topology map is constructed; Multi-level topological features were extracted from the family history topology map, gene mutation topology map, and environmental exposure topology map. Implementing adaptive attention gating specifically includes: Construct a multi-scale risk filter sequence; Based on the multi-scale risk filter sequence, a persistent coherence analysis is performed to generate persistent barcode and Betti number sequences; Based on the continuous barcode and Betty number sequence, a homology sensitivity matrix is ​​constructed; When a coexistence pattern of gene mutation and environmental toxin is detected, the interaction coefficient is calculated based on the homology sensitivity matrix. When the interaction coefficient exceeds a preset threshold, a cross-modal risk amplification mechanism is triggered. Conducting a risk assessment specifically includes: Construct homotopy group coding to form a cross-modal cooperative amplification network; Based on the aforementioned cross-modal collaborative amplification network, a comprehensive lung cancer risk score is calculated; Generate a risk decomposition report, which includes genetic risk, environmental risk, family risk, and synergistic amplification factor; Execution feedback optimization, specifically including: Calculate the rate of change of topological entropy; When the rate of change of the topological entropy exceeds a preset fluctuation threshold, the adaptive attention gating parameters are adjusted. The multi-scale risk filter sequence was optimized based on clinical validation data.

[0018] The present invention has the following beneficial effects: 1. Achieving deep fusion of multimodal data: This invention constructs a heterogeneous graph network through topological theory, transforming three different types of data—family history, gene mutation, and environmental exposure—into a topological structure with a unified mathematical representation, thereby achieving effective fusion of heterogeneous data.

[0019] 2. Precise quantification of risk factor interactions: This invention innovatively introduces continuous coherence analysis technology, which can identify and quantify complex interaction patterns between risk factors at multiple scales. When a high-risk interaction pattern is detected (such as the coexistence of high-risk TP53 variants and radon exposure in the mining area), the interaction coefficient is automatically increased to achieve accurate risk assessment.

[0020] 3. Dynamically adapting to changes in risk: The feedback optimization module designed in this invention can monitor changes in topological features in real time and automatically adjust model parameters by calculating the rate of change of topological entropy, enabling the system to dynamically adapt to changes in individual risk factors.

[0021] 4. Provides interpretable risk assessment results: The risk decomposition report generated by this invention clearly shows the specific contributions of genetic risk, environmental risk, family risk, and synergistic amplification factors, providing a scientific basis for clinicians to develop targeted intervention plans.

[0022] 5. Improved screening accuracy: In clinical trials, this invention demonstrated high predictive accuracy (AUC of 0.91) and significantly reduced the false positive rate (by 40%), providing support for the optimal allocation of medical resources. Attached Figure Description

[0023] Figure 1This is a schematic diagram of the overall architecture of the multimodal lung cancer risk dynamic assessment system of the present invention; Figure 2 This is a schematic diagram of the topology characterization module of the present invention; Figure 3 This is a schematic diagram of the adaptive attention gating module of the present invention; Figure 4 This is a schematic diagram of the risk assessment module of the present invention; Figure 5 This is a schematic diagram of the feedback optimization module of the present invention; Figure 6 This is a flowchart of the multimodal lung cancer risk dynamic assessment method of the present invention. Detailed Implementation

[0024] Please refer to the attached document. Figure 1-6 The preferred embodiments of the present invention will now be described in detail with reference to the accompanying drawings. It should be understood that the preferred embodiments described herein are for illustration and explanation only and are not intended to limit the present invention.

[0025] Reference Figure 1 The multimodal lung cancer risk dynamic assessment system provided by the present invention includes: a data acquisition module 1, a topology representation module 2, an adaptive attention gating module 3, a risk assessment module 4, and a feedback optimization module 5.

[0026] Data acquisition module 1 is used to collect multimodal data, including user family pedigree data, germline gene sequencing data, and environmental exposure data. Topology representation module 2, connected to data acquisition module 1, is used to convert the collected multimodal data into topological representations. Adaptive attention gating module 3, connected to topology representation module 2, is used to perform continuous cohomology analysis and calculate interaction coefficients. Risk assessment module 4, connected to adaptive attention gating module 3, is used to construct a cross-modal collaborative amplification network and calculate a comprehensive lung cancer risk score. Feedback optimization module 5, connected to risk assessment module 4 and adaptive attention gating module 3, is used to monitor system performance and optimize model parameters.

[0027] Data acquisition module 1 is mainly responsible for collecting three types of key data: family pedigree data, germline gene sequencing data, and environmental exposure data.

[0028] In one embodiment of the present invention, the data acquisition module 1 collects user family genealogy data through a structured questionnaire, including lung cancer history and blood relations of three generations of relatives. For example, it collects lung cancer history of immediate family members such as parents, siblings, and children, as well as lung cancer history of second-generation relatives such as grandparents, maternal grandparents, uncles, aunts, and cousins. Preferably, a higher weight (e.g., 0.85) is assigned to the illness status of immediate family members, and a decreasing weight is assigned to collateral relatives (e.g., 0.5 for second-generation relatives and 0.25 for third-generation relatives).

[0029] For germline gene sequencing data, data acquisition module 1 uses a saliva sample collection unit and a DNA sequencing unit for collection and processing. In practical applications, the saliva sample collection unit collects user saliva samples using a standardized collection box, with the collection volume controlled at 2-5 ml to ensure DNA extraction quality. The DNA sequencing unit uses next-generation sequencing (NGS) technology for high-throughput sequencing, focusing on functional domain mutation sites of lung cancer driver genes such as TP53 and EGFR. Preferably, the sequencing depth is set to 30-50X to ensure detection sensitivity and specificity.

[0030] Environmental exposure data is collected through an environmental data collection unit, including users' occupational history and geographical information records over the past 30 years. This unit collects users' historical residence and workplace information through structured questionnaires and interfaces with an environmental monitoring database to obtain historical concentration data of environmental pollutants such as PM2.5 and radon at the corresponding times and locations. For example, for a mining work history, the specific mine location, working hours, and job position are recorded, and historical radon concentration data for that mine area are linked; for a city residence history, historical PM2.5 concentration data for that city are linked.

[0031] For PM2.5 exposure, the cumulative exposure over 30 years can be calculated. : , in, This refers to the cumulative exposure to PM2.5 (unit: μg·year / m3). The average PM2.5 concentration for the i-th time period (unit: ), The duration of the time period is denoted by n (in years), and n is the total number of time periods. This calculation method combines concentration with exposure time, and can more accurately reflect the long-term cumulative health effects of exposure.

[0032] Preferably, the data acquisition module 1 also includes a data preprocessing function to clean, standardize, and preliminarily structure the raw data to prepare for subsequent topological representation. For example, it may impute missing data, handle outliers, and perform unified format conversion on data from different sources. For different types of data, appropriate normalization methods are used to map data values ​​to the [0,1] interval, eliminating dimensional differences.

[0033] Reference Figure 2 The topological characterization module 2 includes a family history topology unit 21, a gene mutation topology unit 22, an environmental exposure topology unit 23, and a multi-level feature extraction unit 24.

[0034] Family history topology unit 21 receives family pedigree data and constructs a directed graph of family relationships. In this directed graph, nodes represent family members, and edges represent blood relationships. High weights (preferably 0.85) are assigned to direct relatives who have the disease, while decreasing weights (preferably 0.5-0.3) are assigned to collateral relatives. Furthermore, this unit calculates the shortest paths between nodes to reflect the strength of genetic risk transmission. For example, a path length of 1 for a father-son relationship indicates direct genetic risk transmission; a path length of 2 for a grandparent-grandchild relationship indicates indirect genetic risk transmission.

[0035] Gene mutation topology unit 22 receives germline gene sequencing data, identifies gene mutation sites, and constructs a functional network. In this network, nodes represent mutation sites, and edges represent functional associations. This unit classifies mutations into three levels: high-risk, intermediate-risk, and low-risk. Preferably, high-risk mutations include hotspot mutations such as R175H, R248Q, and R273H in TP53, and mutations such as T790M and L858R in EGFR; intermediate-risk mutations include mutations such as G12C and G12V in KRAS; and low-risk mutations include some common polymorphic sites. This unit calculates the topological centrality and clustering coefficient of functional domain mutations to generate a gene mutation topology map.

[0036] Environmental exposure topology unit 23 receives environmental exposure data and constructs a spatiotemporal exposure network. In this network, nodes represent exposure events, and edges represent spatiotemporal correlations. This unit calculates cumulative exposure and constructs an exposure intensity heatmap. This unit extracts exposure peaks and sustained exposure patterns, such as high exposure periods where radon concentration exceeds 20 mBq / m³, or PM2.5 concentrations consistently exceeding 75 μg / m³ for more than 3 months. These peaks and sustained patterns have a more significant impact on lung cancer risk.

[0037] The multi-level feature extraction unit 24 extracts topological features at three levels—micro, meso, and macro—from three types of topological graphs. Micro-level topological features include degree centrality, betweenness centrality, and proximity centrality, used to characterize risk features at the node level; meso-level topological features include community partitioning, modularity, and inter-community connectivity, used to characterize risk features at the group level; and macro-level topological features include network diameter, average path length, and clustering coefficient, used to characterize risk features at the overall network level.

[0038] Degree centrality can be expressed as: , in, Determine the degree centrality of node v (with values ​​in the range [0,1]). This indicates the number of connections to node v. This represents the total number of nodes in the network. Higher degree centrality indicates that the risk factor has more connections with other factors and a wider range of influence.

[0039] The centrality of the middle can be represented as: , in, Let v be the betweenness centrality of node v, and s and t be any two nodes in the network. , This represents the total number of shortest paths from node s to node t. This represents the number of shortest paths from s to t that pass through node v. Betweenness centrality reflects the "bridging" role of a node in the network; risk factors with high betweenness centrality play a crucial role in the risk transmission process.

[0040] These topological features collectively constitute a multi-level topological feature vector set, providing input for subsequent continuous homology analysis. For each topological graph, the dimension of the feature vector depends on the number of extracted features, typically 10-20 dimensions. After standardization, these feature vectors are passed to an adaptive attention gating module for further analysis.

[0041] Reference Figure 3 The adaptive attention gating module 3 includes a multi-scale filter construction unit 31, a continuous coherence calculation unit 32, and an interaction coefficient calculation unit 33.

[0042] Multi-scale filter building unit 31 defines the risk threshold sequence The threshold sequence increases from low risk to high risk. Preferably, the threshold sequence employs a non-linear growth strategy, with dense sampling in low-risk intervals (e.g., interval 0.05) and sparse sampling in high-risk intervals (e.g., interval 0.1). For example, it can be set... For each risk threshold Construct a set of subgraphs Only nodes and edges with risk values ​​greater than or equal to the threshold are retained to form nested sequences. .

[0043] The persistent coherence computing unit 32 receives a multi-scale topological description, tracks the "birth" and "death" of topological features, and generates a persistent barcode map. In this map, the horizontal axis represents a risk threshold, and the bars represent the threshold range in which a feature persists. Preferably, barcodes with a length exceeding half of the threshold range are identified as stable, critical risk structures. For example, if a topological feature persists within a threshold range of 0.2 to 0.7, and its barcode length is 0.5, which is greater than half of the total threshold range of 0.8, it is identified as a critical risk structure.

[0044] This unit also calculates the Betty number sequence under different risk thresholds. ,in These represent the number of connected components, ring structures, and void structures, respectively. The formula for calculating the Betti number sequence is: , in, Risk threshold The k-th order Betti number, It is a k-dimensional cyclic group (representing a set of k-dimensional cycles). It is a k-dimensional boundary group (a set representing k-dimensional boundaries). This represents the rank of the group (the number of free generators). For example, Indicates the number of connected components. Indicates the number of ring structures. This represents the number of void structures. When the first-order Betti number... When the value suddenly increases (e.g., the increase exceeds 50%), it indicates the formation of a circular risk structure, triggering a synergistic amplification mechanism.

[0045] The interaction coefficient calculation unit 33 analyzes the persistent barcode crossover patterns of gene-environment factor pairs and calculates the interaction strength coefficient based on the degree of barcode overlap and persistence. (Interaction strength coefficient) The calculation formula is: , in, The interaction strength coefficient of gene-environment factor pairs (within the range of [0,1]). Indicates the barcode overlap length. Indicates the total length of the barcode. Indicates the persistence of the overlapping area (which can be calculated from the barcode height of the overlapping area). Indicates total durability. The interaction coefficient is a weighting factor (preferably 0.6, representing the weight of the overlap length). When a high-risk topology is detected (such as the coexistence of high-risk TP53 variants and radon exposure in the mining area), the interaction coefficient is increased to a preset threshold (0.92) or higher.

[0046] In practical applications, different thresholds can be set according to different types of gene-environment interaction patterns. For example, the threshold is set at 0.92 for the coexistence of high-risk TP53 variants and radon exposure in mining areas; at 0.88 for the coexistence of EGFR mutations and high PM2.5 exposure; and at 0.85 for the coexistence of KRAS mutations and a history of smoking. These thresholds are based on clinical validation data and can more accurately reflect the risk levels of different interaction patterns.

[0047] Reference Figure 4 The risk assessment module 4 includes a homotopy group encoding unit 41, a collaborative amplification unit 42, and a risk report generation unit 43.

[0048] The homotopy group encoding unit 41 computes the fundamental group for each topological space, capturing the toroidal structure of the space. Fundamental group The calculation is based on the equivalence classes of the loop: , in, Represents the topological space X at the base point The basic group of the place, Represents a loop (from) Departure and return (continuous mapping) express From the interval Mapping to space X, This indicates that the starting and ending points of the loop are both... , Indicates a loop Equivalence class (all with) (A set of homotopic loops). The fundamental group reflects the structure of "non-shrinkable loops" in the topological space. In lung cancer risk assessment, these loop structures often represent closed-loop reinforcement mechanisms formed by multiple risk factors.

[0049] This unit constructs a homotopy mapping. This involves establishing topological equivalence relations between different modalities, calculating homotopy group invariants, and identifying essential characteristics of topological structures. For example, it includes calculating the Eulerian characteristic number of a topological space. ,in It is the k-th order Betti number of X. The Euler characteristic is a topological invariant that can be used to distinguish different types of topological structures.

[0050] The collaborative amplification unit 42 calculates the interaction strength between homotopic groups of data from different modalities and identifies data combinations with highly coupled homotopic groups. When the coupling strength exceeds a threshold (preferably 0.85), the collaborative amplification mechanism is triggered. This invention sets up a three-level collaborative amplification mechanism: primary collaborative, intermediate collaborative, and advanced collaborative.

[0051] Primary synergy is triggered when a single high-risk factor is present, with an amplification factor of 1.2 times the original risk. For example, when a high-risk TP53 mutation is detected but no other high-risk factors are present, the base risk score is multiplied by 1.2. Intermediate synergy is triggered when two types of risk factors coexist, with an amplification factor of 1.8 times the original risk. For example, when a high-risk TP53 mutation and a family history of high risk are detected simultaneously, the base risk score is multiplied by 1.8. Advanced synergy is triggered when three types of risk factors resonate, with an amplification factor of 2.5 times the original risk. For example, when a high-risk TP53 mutation, a family history of high risk, and a history of high radon exposure in the mining area are detected simultaneously, the base risk score is multiplied by 2.5.

[0052] The risk report generation unit 43 receives the adjusted risk score, breaks down the risk components, identifies the main risk factors, and generates a risk decomposition report. This report includes genetic risk, environmental risk, family risk, and synergistic amplification factors, and provides personalized intervention recommendations. For example, for individuals with predominantly genetic risk, it recommends strengthening gene-targeted prevention; for individuals with predominantly environmental risk, it recommends optimizing their living environment and occupational protection.

[0053] Risk scoring typically uses a standard 0-100 scale, with scores above 70 indicating high risk, 50-70 indicating medium risk, and below 50 indicating low risk. This grading method aligns with clinical practice and is easy for physicians to understand and use. In the risk decomposition report, the contribution percentage of each risk factor is calculated through normalization to ensure a total of 100%. The synergistic amplification factor is presented as a separate item, reflecting the strength of the interaction between risk factors.

[0054] Reference Figure 5 The feedback optimization module 5 includes a topology entropy monitoring unit 51, a parameter adjustment unit 52, and a model verification unit 53.

[0055] The topological entropy monitoring unit 51 continuously monitors changes in topological characteristics and calculates the rate of change of topological entropy. The formula for calculating topological entropy S is: , Where S is the topological entropy (unit: bits). The importance probability of node i is represented by a normalized centrality index, satisfying the condition that... , where i is the node index in the network, and the summation range includes all nodes in the network. Topological entropy quantifies the complexity and uncertainty of a network. The higher the entropy value, the more complex the network structure and the more uniform the risk distribution; the lower the entropy value, the simpler the network structure and the more concentrated the risk is at a few key nodes.

[0056] topological entropy change rate The calculation formula is: , in, The rate of change of topological entropy (dimensionless) This represents the topological entropy at the current time t. Indicates the previous moment The topological entropy is calculated. An alarm signal is generated when the rate of change of topological entropy exceeds a preset fluctuation threshold (preferably 0.15). The choice of 0.15 as the threshold is based on clinical validation data, ensuring system stability while responding promptly to significant changes in model performance.

[0057] The parameter adjustment unit 52 receives the alarm signal, generates a parameter adjustment instruction, and sends the instruction to the adaptive attention gating module 3. The parameter adjustment instruction includes suggestions for adjusting the multi-scale filter threshold sequence, continuous cohomology calculation parameters, and interaction coefficient calculation parameters. For example, when a decrease in risk assessment accuracy is detected, it may be necessary to adjust the threshold interval of the multi-scale filter or adjust the trade-off coefficients in the interaction coefficient calculation. .

[0058] Specifically, when the system's recognition rate for high-risk groups decreases, the starting threshold of the multi-scale filter can be appropriately reduced (e.g., from 0.1 to 0.05) and the threshold interval can be reduced (e.g., from 0.05 to 0.03 in the low-risk range) to improve the system's sensitivity to risk factors. When the system's false positive rate increases, the tradeoff coefficient α can be appropriately increased (e.g., from 0.6 to 0.7) and the weight of the barcode overlap length in the interaction coefficient calculation can be increased to improve the system's specificity.

[0059] The model validation unit 53 receives clinical validation data, evaluates the model's predictive accuracy, identifies prediction error patterns, and optimizes model parameters based on these patterns. For example, it calculates the AUC value through ROC curve analysis to assess the model's ability to identify high-risk populations; and it calculates sensitivity and specificity through confusion matrix analysis to assess the model's false positive and false negative rates.

[0060] In clinical validation, the model's target performance metrics are: AUC value no less than 0.85, sensitivity no less than 80%, and specificity no less than 75%. When the performance metrics fall below the target values, the system automatically triggers a parameter optimization process. The optimization method employs a Bayesian optimization algorithm, which efficiently searches for the optimal parameter combination in the parameter space, typically converging to a relatively good solution within 5-10 iterations.

[0061] The following specific embodiment illustrates the workflow and application effects of the present invention.

[0062] Suppose a 55-year-old male user undergoes a lung cancer risk assessment using this system. First, data acquisition module 1 collects the user's pedigree data, recording that his father and an uncle had both had lung cancer; germline gene sequencing data is collected, detecting a high-risk R175H mutation in the TP53 gene; environmental exposure data is collected, revealing that the user has a 10-year history of working in a mining area, where the historical radon concentration was 20 mBq / m³, exceeding the safety threshold (10 mBq / m³).

[0063] Topological representation module 2 converts this data into topological representations. Family history topology unit 21 constructs a directed graph of family relationships, assigning a weight of 0.85 to the father's disease and 0.3 to the uncle's disease. Gene mutation topology unit 22 identifies the high-risk TP53R175H mutation and assigns it a high pathogenicity level. Environmental exposure topology unit 23 constructs a spatiotemporal exposure network, calculating the 10-year cumulative radon exposure in the mining area to be 200 mBq·year / m³. Multi-level feature extraction unit 24 extracts features from the three topological graphs, forming a multi-level topological feature vector set.

[0064] The adaptive attention gating module 3 performs persistent cohomology analysis. The multi-scale filter construction unit 31 defines a risk threshold sequence ε = {0.1, 0.15, 0.2, …, 0.9} and constructs a subgraph set sequence. The persistent cohomology calculation unit 32 generates a persistent barcode map, finding that the TP53R175H mutation and radon exposure in the mining area form stable long barcodes (covering the threshold range of 0.2-0.7), and at the first-order Betti number... A 75% surge was observed (from 2 to 3.5), indicating the formation of a ring-shaped risk structure. The interaction coefficient calculation unit 33 analyzes the barcode crossover pattern and calculates the interaction strength coefficient. If the value exceeds the preset threshold of 0.92, the cross-modal risk amplification mechanism is triggered.

[0065] Risk assessment module 4 constructs a cross-modal collaborative amplification network. Homotope group encoding unit 41 calculates the basic group, constructs the homotope mapping, and identifies the topological equivalence relations of gene-environment interactions. Collaborative amplification unit 42 detects the coexistence of two types of factors: high-risk genes and high-risk environments, triggering intermediate-level collaboration with an amplification factor of 1.8 times. Risk report generation unit 43 calculates a comprehensive lung cancer risk score of 78 points (out of 100), belonging to the high-risk level (score ≥70 is high-risk), and generates a risk decomposition report: gene risk contributes 40%, environmental risk contributes 35%, family risk contributes 25%, and the collaborative amplification factor is 1.8 times.

[0066] Feedback optimization module 5 monitors system performance. Topology entropy monitoring unit 51 calculates the rate of change of topology entropy. The fluctuation did not exceed the preset fluctuation threshold of 0.15, and the system parameters remained stable. The model validation unit 53 received the user's clinical follow-up data for the next three years and found that the user was found to have early lung nodules through low-dose CT scan in the second year. After biopsy, the user was diagnosed with early-stage lung adenocarcinoma and achieved a good prognosis through timely intervention, which verified the predictive accuracy of the system.

[0067] Reference Figure 6 The present invention also provides a multimodal dynamic assessment method for lung cancer risk, comprising the following steps: Step S1: Collect multimodal data, including user family pedigree data, germline gene sequencing data, and environmental exposure data.

[0068] Preferably, the pedigree data collection includes recording the lung cancer history and blood relationship of three generations of relatives; the germline gene sequencing data collection includes saliva sample collection, DNA extraction and high-throughput sequencing; the environmental exposure data collection includes recording the user's 30-year occupational trajectory and residence history, and linking it to the environmental monitoring database to obtain historical pollutant concentration data.

[0069] Step S2: Construct topological representations. Based on multimodal data, construct family history topology maps, gene mutation topology maps, and environmental exposure topology maps, and extract multi-level topological features.

[0070] Preferably, when constructing a family history topology graph, family members are set as nodes, blood relations are set as edges, and diseases of direct relatives are assigned a high weight of 0.85; when constructing a gene mutation topology graph, mutation sites are set as nodes, functional associations are set as edges, and mutations are divided into three levels: high risk, intermediate risk, and low risk; when constructing an environmental exposure topology graph, exposure events are set as nodes, spatiotemporal associations are set as edges, and cumulative exposure is calculated.

[0071] Step S3: Perform adaptive attention gating, including constructing a multi-scale risk filter sequence, performing continuous cohomology analysis, calculating interaction coefficients, and triggering a cross-modal risk co-amplification mechanism when a high-risk interaction pattern is detected.

[0072] Preferably, the construction of the multi-scale risk filter sequence adopts a non-linear growth strategy, with dense sampling in low-risk intervals and sparse sampling in high-risk intervals; continuous homology analysis generates a continuous barcode map and Betti number sequence, and a collaborative amplification mechanism is triggered when the first-order Betti number suddenly increases; the interaction coefficient is calculated based on the degree of barcode overlap and persistence, and when the coefficient exceeds 0.92, it is automatically upgraded to a high-risk level.

[0073] Step S4: Conduct risk assessment, including constructing homotopy group coding, forming a cross-modal collaborative amplification network, calculating a comprehensive lung cancer risk score, and generating a risk decomposition report.

[0074] Preferably, the homotopy group encoding captures the ring structure of the topological space by calculating the basic group; the cooperative amplification network sets up a three-level amplification mechanism, including primary cooperative (1.2 times), intermediate cooperative (1.8 times) and advanced cooperative (2.5 times); the risk decomposition report includes the specific contribution ratios of genetic risk, environmental risk, family risk and cooperative amplification factor.

[0075] Step S5: Perform feedback optimization, including calculating the rate of change of topological entropy, adjusting model parameters when the rate of change exceeds a preset fluctuation threshold, and continuously optimizing system performance based on clinical validation data.

[0076] Preferably, the topological entropy is obtained by the entropy calculation formula of the node importance probability, and parameter adjustment is triggered when the topological entropy change rate exceeds 0.15; the model validation evaluates the prediction accuracy through methods such as ROC curves and confusion matrices, and optimizes the model parameters based on the evaluation results.

[0077] The multimodal lung cancer risk dynamic assessment system and method of the present invention are applicable to a variety of clinical application scenarios: 1. High-risk lung cancer screening: Risk assessment is conducted for smokers over 40 years of age and individuals with a family history of lung cancer, and personalized screening plans are developed based on the assessment results. For example, high-risk individuals with a score ≥70 are advised to undergo a low-dose CT scan every six months; medium-risk individuals with a score of 50-70 are advised to undergo a low-dose CT scan annually; and low-risk individuals with a score <50 can extend the screening interval.

[0078] 2. Personalized Intervention Management: Based on risk breakdown reports, targeted intervention recommendations are provided for individuals with different risk types. For example, for individuals with predominantly genetic risk, regular genetic targeting monitoring is recommended; for individuals with predominantly environmental risk, optimizing their work and living environment and reducing exposure to harmful substances is recommended; for individuals with predominantly family risk, increasing screening frequency and conducting risk assessments for immediate family members are recommended.

[0079] 3. Clinical research support: Constructing high-risk population cohorts for long-term follow-up, evaluating the effects of different interventions, and identifying new risk factors and interaction patterns. For example, the impact of the interaction between different gene mutations and environmental factors on the incidence of lung cancer can be studied, providing a scientific basis for precision prevention.

[0080] In summary, this invention innovatively integrates topological theory with multimodal medical data analysis to establish a complete, reliable, and efficient dynamic assessment method for lung cancer risk, providing a powerful tool for early prevention and intervention of lung cancer and demonstrating the unique value and broad application prospects of mathematical theory in the medical field.

[0081] The embodiments described above are merely illustrative of specific implementations of the present invention, and while the descriptions are detailed, they should not be construed as limiting the scope of the present invention. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of the present invention, and these modifications and improvements all fall within the scope of protection of the present invention.

Claims

1. A multimodal dynamic assessment system for lung cancer risk, characterized in that, include: The data acquisition module is used for: Collect user family genealogy data, which includes lung cancer history and blood relationship among three generations of relatives; Collect germline gene sequencing data, which includes user gene mutation information; Collect environmental exposure data, which includes historical records of users' occupational trajectories and geographic information; The topology characterization module, connected to the data acquisition module, is used for: Receive the family genealogy data and construct a family history topology map; Receive the germline gene sequencing data, identify mutation sites in driver gene functional domains, and construct a gene mutation topology map; Receive the environmental exposure data and construct an environmental exposure topology map; Multi-level topological features were extracted from the family history topology map, gene mutation topology map, and environmental exposure topology map. The adaptive attention gating module, connected to the topology representation module, is used for: Receive the multi-level topological features; Construct a multi-scale risk filter sequence; Based on the multi-scale risk filter sequence, a persistent coherence analysis is performed to generate persistent barcode and Betti number sequences; Based on the continuous barcode and Betty number sequence, a homology sensitivity matrix is ​​constructed; When a coexistence pattern of gene mutation and environmental toxin is detected, the interaction coefficient is calculated based on the homology sensitivity matrix. When the interaction coefficient exceeds a preset threshold, a cross-modal risk amplification mechanism is triggered. The risk assessment module, connected to the adaptive attention gating module, is used for: Receive the interaction coefficient; Construct homotopy group coding to form a cross-modal cooperative amplification network; Based on the aforementioned cross-modal collaborative amplification network, a comprehensive lung cancer risk score is calculated; Generate a risk decomposition report, which includes genetic risk, environmental risk, family risk, and synergistic amplification factor; The feedback optimization module, connected to the risk assessment module and the adaptive attention gating module, is used for: Receive the comprehensive lung cancer risk score and clinical validation data; Calculate the rate of change of topological entropy; When the rate of change of the topological entropy exceeds the preset fluctuation threshold, a parameter adjustment instruction is sent to the adaptive attention gating module; Based on the clinical validation data, the multi-scale risk filter sequence was optimized.

2. The multimodal lung cancer risk dynamic assessment system according to claim 1, characterized in that, The topology characterization module includes: Family history topology unit, used for: Receive the family pedigree data; Construct a directed graph of family relationships, setting family members as nodes and blood relations as edges; The incidence of illness among immediate family members is given a high weight, while the incidence of illness among collateral family members is given a decreasing weight. Calculate the shortest path between nodes and generate a family history topology graph; Gene mutation topology unit, used for: Receive the germline gene sequencing data; Identify gene mutation sites, construct functional networks, and set mutation sites as nodes and functional associations as edges; The mutation sites were stratified into three levels: high-risk, intermediate-risk, and low-risk. Calculate the topological centrality and clustering coefficient of functional domain mutations to generate a gene mutation topology map; Environmentally exposed topology units are used for: Receive the environmental exposure data; Construct a spatiotemporal exposure network, setting exposure events as nodes and spatiotemporal associations as edges; Calculate cumulative exposure and construct an exposure intensity heatmap; Extract exposure peak points and continuous exposure patterns to generate an environmental exposure topology map; Multi-level feature extraction unit, used for: Microscopic, mesoscopic, and macroscopic topological features are extracted from the family history topology map, gene mutation topology map, and environmental exposure topology map. The microscopic, mesoscopic, and macroscopic topological features are organized into a multi-level topological feature vector set.

3. The multimodal lung cancer risk dynamic assessment system according to claim 1, characterized in that, The adaptive attention gating module includes: Multi-scale filter building blocks are used for: Define a risk threshold sequence that increases from low risk to high risk; For each risk threshold, construct a subgraph set, retaining only nodes and edges whose risk values ​​are greater than or equal to that threshold; Form nested sequences to generate multi-scale topological descriptions; The continuous coherence calculation unit, connected to the multi-scale filter construction unit, is used for: Receive the multi-scale topology description; Track the appearance and disappearance of topological features to generate a persistent barcode map; Calculate the Betty number sequence to quantify topological changes under different risk thresholds; Identify Betty number mutation points to indicate key risk topological shifts; The interaction coefficient calculation unit, connected to the continuous coherence calculation unit, is used for: Analyze the persistent barcode crossover patterns of gene-environment pairs; The interaction strength coefficient is calculated based on the degree of barcode overlap and persistence. Apply a piecewise smoothing function to ensure the continuity of coefficient changes; When a high-risk topology is detected, the interaction coefficient will be increased to a level above a preset threshold.

4. The multimodal lung cancer risk dynamic assessment system according to claim 1, characterized in that, The risk assessment module includes: Hotopy group coding unit, used for: Calculate the fundamental group for each topological space to capture the toroidal structure of the space; Construct homotopy mappings to establish topological equivalence relationships between data of different modalities; Calculate homotopy group invariants to identify essential characteristics of topological structures; Constructing a risk representation space based on homotopy group characteristics; The cooperative amplification unit, connected to the homotopy group encoding unit, is used for: Calculate the interaction strength between homotopy groups of data from different modalities; Identify data combinations with highly coupled homotopy groups; When the coupling strength exceeds the threshold, the cooperative amplification mechanism is triggered; The risk score is dynamically adjusted to reflect the synergistic effect of multiple factors. The risk report generation unit, connected to the collaborative amplification unit, is used for: Receive the adjusted risk score; Decompose the risk components and identify the main risk factors; Generate a risk breakdown report; Provide personalized intervention recommendations.

5. The multimodal lung cancer risk dynamic assessment system according to claim 1, characterized in that, The feedback optimization module includes: Topological entropy monitoring unit, used for: Continuously monitor changes in topological features; Calculate the rate of change of topological entropy; An alarm signal is generated when the rate of change of topological entropy exceeds a preset fluctuation threshold. The parameter adjustment unit, connected to the topology entropy monitoring unit, is used for: Receive the alarm signal; Generate parameter adjustment instructions; The parameter adjustment command is sent to the adaptive attention gating module; Model validation unit, used for: Receive clinical validation data; Assess the accuracy of model predictions; Identify prediction error patterns; Optimize model parameters based on prediction error patterns.

6. The multimodal lung cancer risk dynamic assessment system according to claim 1, characterized in that, The data acquisition module also includes: Saliva sample collection unit, used for: Collect saliva samples from users; Extracting user genomic DNA; Quality control was performed on the genomic DNA; The DNA sequencing unit, connected to the saliva sample collection unit, is used for: Receive the genomic DNA; Constructing DNA sequencing libraries; Perform high-throughput sequencing; Generate raw sequencing data; Environmental data collection unit, used for: Collect users' historical occupational data; Collect historical data on users' residential locations; Obtain historical pollutant concentration data from environmental monitoring databases; Link user location and environmental monitoring data to generate a personalized environmental exposure history.

7. The multimodal lung cancer risk dynamic assessment system according to claim 2, characterized in that, The microscopic topological features extracted by the multi-level feature extraction unit include: Degree centrality, which represents the number of node connections and reflects the scope of influence of risk factors; Intermediation centrality, which represents the importance of a node's position in a path and reflects its risk transmission capability; Proximity centrality, which represents the average distance from a node to other nodes, reflects the speed of risk diffusion; The mesoscopic topological features include: Community segmentation, which is used to identify highly correlated risk factor groups; Modularity, which is used to assess the clarity of risk factor grouping; Inter-community connectivity, which is used to assess the intensity of interaction between different risk groups; The macroscopic topological features include: Network diameter, which represents the length of the longest and shortest paths, reflects the scope of risk impact; Average path length, which represents the average distance between nodes and reflects the efficiency of risk transmission; Clustering coefficient, which represents the overall degree of clustering of the network and reflects the degree of risk coordination.

8. The multimodal lung cancer risk dynamic assessment system according to claim 3, characterized in that, The Betty number sequence generated by the continuous homology calculation unit includes: The zero-order Betti number, which represents the number of connected components; The first-order Betti number, which represents the number of ring structures; The second-order Betti number, which represents the number of void structures; Among them, when the first-order Betty value suddenly increases, it indicates the formation of a ring-shaped risk structure, triggering a collaborative amplification mechanism; and the formation of a high-risk interaction mode based on the dynamic change rate of the Betty number.

9. The multimodal lung cancer risk dynamic assessment system according to claim 4, characterized in that, The collaborative amplification unit is equipped with a three-level collaborative amplification mechanism, including: Primary synergy, which is triggered when a single high-risk factor is present, has an amplification factor of 1.2 times the original risk; Intermediate synergy, which is triggered when two types of risk factors coexist, has an amplification factor of 1.8 times that of the original risk; Advanced synergy, which is triggered when three types of risk factors resonate, has an amplification factor of 2.5 times that of the original risk; The risk factors include high-risk gene mutations, a high-risk family history of genetic disease, and a history of high environmental exposure.

10. A multimodal dynamic assessment method for lung cancer risk, characterized in that, Includes the following steps: Collect multimodal data, including user family pedigree data, germline gene sequencing data, and environmental exposure data; Constructing topological representations specifically includes: Based on the aforementioned family pedigree data, a family history topology map is constructed; Based on the germline gene sequencing data, mutation sites in driver gene functional domains were identified, and a gene mutation topology map was constructed. Based on the environmental exposure data, an environmental exposure topology map is constructed; Multi-level topological features were extracted from the family history topology map, gene mutation topology map, and environmental exposure topology map. Implementing adaptive attention gating specifically includes: Construct a multi-scale risk filter sequence; Based on the multi-scale risk filter sequence, a persistent coherence analysis is performed to generate persistent barcode and Betti number sequences; Based on the continuous barcode and Betty number sequence, a homology sensitivity matrix is ​​constructed; When a coexistence pattern of gene mutation and environmental toxin is detected, the interaction coefficient is calculated based on the homology sensitivity matrix. When the interaction coefficient exceeds a preset threshold, a cross-modal risk amplification mechanism is triggered. Conducting a risk assessment specifically includes: Construct homotopy group coding to form a cross-modal cooperative amplification network; Based on the aforementioned cross-modal collaborative amplification network, a comprehensive lung cancer risk score is calculated; Generate a risk decomposition report, which includes genetic risk, environmental risk, family risk, and synergistic amplification factor; Execution feedback optimization, specifically including: Calculate the rate of change of topological entropy; When the rate of change of the topological entropy exceeds a preset fluctuation threshold, the adaptive attention gating parameters are adjusted. The multi-scale risk filter sequence was optimized based on clinical validation data.